☰
✕

Intravenous solutions market

Intravenous Solutions Market, by Solution (Saline (Normal Saline (0.9% NaCl) and Hypertonic Saline), Dextran, Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, and Mixed Solutions), by Bag Type (Large Volume Bags (greater than 250ml) and Small Volume Bags (less than 250ml)), by Application (Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, and Irrigation IV Solution), by End User (Hospitals, Clinics, Ambulatory Surgery Centers, and Home Care Settings), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Request Free Sample
  • Mar 2024
  • CMI1134
  • 215 Pages
  • Excel & Pdf
  • Pharmaceutical

Intravenous solutions (IV) are administered in patients to provide sugar, salt and water directly into venous circulation. IV solutions and electrolytes are used for fluid resuscitation, routine maintenance, replacement, and redistribution. Nowadays, intravenous drugs, nutrition and mixed solutions have become an integral part of modern therapy. The intravenous route of administration is commonly used for rehydration or to provide nutrients for those who cannot, or will not, due to reduced mental states or otherwise, consume food or water by mouth. It may also be used to administer medications or other medical therapy such as blood products or electrolytes to correct electrolyte imbalances.

Global intravenous solutions market is estimated to be valued at USD 11.04 Bn in 2024 and is expected to exhibit a CAGR of 6.1% during the forecast period (2024-2031).

Figure 1. Global Intravenous Solutions Market Value (US$ Bn), by Region, 2024

Increasing launches and regulatory approvals for intravenous solution injection is expected to drive growth of the global intravenous solution market

Market players are involved in launching new intravenous injection solutions which is expected to boost the growth of global intravenous solutions market over the forecast period. For instance, in September 2021, Baxter International Inc., a global sterile medication production company, announced the U.S. Food and Drug Administration (FDA) approval and commercial launch of premix Norepinephrine Bitartrate in 5% Dextrose Injection (norepinephrine). Norepinephrine is indicated to raise blood pressure in adult patients with severe, acute hypotension (low blood pressure). Baxter’s formulation of norepinephrine is the first and only manufacturer-prepared ready-to-use formulation and is available in 4 mg/250 mL (16 mcg/mL) and 8 mg/250 mL (32 mcg/mL) strengths.

Intravenous Solutions Market Report Coverage

Report Coverage Details
Base Year: 2023 Market Size in 2024: US$ 11.04 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 6.1% 2031 Value Projection: US$ 16.69 Bn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Solution type: Saline (Normal Saline (0.9% NaCl) , Hypertonic Saline), Lactated Ringer’s, Amino Acid, Vitamins & Minerals, Heparin and Trace Elements, Mixed Solutions
  • By Bag type: Large Volume Bags (greater than 250ml), Small Volume Bags (less than 250ml)
  • By Application: Basic IV Solution, Nutritional IV Solution, Blood IV Solution, Drug IV Solution, Irrigation IV Solution
  • By End User: Hospitals, Clinics, Ambulatory Surgery Centers, Home Care Settings
Companies covered:

Baxter International Inc., ICU Medical. Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.
Growth Drivers:
  • Increasing launches and regulatory approvals for intravenous solution injection
  • Increasing launches of parenteral (intravenous) nutrition (PN) products
Restraints & Challenges:
  • Increasing recalls of intravenous products

Figure 2. Global Intravenous Solutions Market Share, By Solution, 2024

Increasing launches of parenteral (intravenous) nutrition (PN) products by key market players is attributing to the highest share of North America market in the global intravenous solutions market.

Increasing launches of parenteral (intravenous) nutrition (PN) products by key players in market for developing global intravenous solutions is expected to drive market growth over the forecast period. For instance, in June 2019, Eurolife Healthcare, a manufacturer and distributor of specialty infusion & pharmaceuticals, launched two intravenous IV products: Discport and Lifeport in the India drug market. The product is considered as smart intravenous infusion, which encompasses the latest technology that reduces the chances of any infection.

Global Intravenous Solutions Market– Impact of Coronavirus (COVID-19) Pandemic

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization had declared it a public health emergency on January 30, 2020.

The sudden outbreak of COVID-19 has bought the world to a standstill. The demand for IV solutions has increased due to the fast spread of coronavirus illness (COVID-19), which will allow patients in intensive care units to receive vital nutrients (ICU). In addition to this, a significant growth-inducing element is the rise in diabetes, cancer, gastrointestinal problems, and neurological illnesses. Additionally, IV solution therapy's superior efficacy and quicker response time are fostering market expansion. It is employed to treat chronic dehydration, a disease that can lead to weariness, memory loss, irritability, and other health issues. For instance, in February 2022, the World Health Organization published a report which stated that nearly 10 million deaths in 2020, or nearly one in six deaths globally due to cancer. Cancer-causing infections, such as human papillomavirus (HPV) and hepatitis, are responsible for approximately 30% of cancer cases in low- and lower-middle-income countries like India and Bangladesh.

Thus, impact of the Coronavirus (COVID-19) pandemic has driven growth of the global intravenous solutions market during the forecast period.

Recent Developments

  • In October 2023, Novartis, a global leader in immuno-dermatology and rheumatology, announced that the US Food and Drug Administration (FDA) has approved an intravenous (IV) formulation of Cosentyx (secukinumab) for the treatment of adults suffering from psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non-radiographic axial spondyloarthritis (nr-axSpA). Cosentyx is the only authorized IV formulation that targets and inhibits interleukin-17A (IL-17A), as well as the only non-tumor necrosis factor alpha (TNF-α) IV option accessible in all indications.
  • In February 2023, The U.S. FDA approved ALTUVIIIO [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], formerly known as efanesoctocog alfa, a first-in-class, high-sustained factor VIII replacement treatment. ALTUVIIIO is recommended for regular prophylaxis and on-demand therapy to reduce bleeding episodes, as well as perioperative care (surgery) in adults and children with hemophilia A.
  • In June 2022, Breckenridge Pharmaceutical, Inc., a generic pharmaceutical manufacturing company, announced that the U.S. Food and Drug Administration (FDA) had granted approval for its Abbreviated New Drug Application for Cabazitaxel Intravenous Powder. This product was developed in collaboration with Natco Pharma Limited, a multinational pharmaceutical company.  Breckenridge received final approval for the 60mg/1.5mL (40mg/mL) strength.
  • In May 2022, SIGA Technologies, Inc., a commercial-stage pharmaceutical company focused on the health security market, announced that the U.S. FDA had approved an intravenous (IV) version of TPOXX for the treatment of smallpox. The IV formulation is a significant option for patients who are unable to take TPOXX's oral capsules.
  • In July 2021, Grifols, a prominent  global supplier of plasma-derived pharmaceuticals, announced that it would establish an intravenous (IV) solutions manufacturing facility in Nigeria for Dozie and Dozie's Pharma Nig Ltd., a leading distributor of healthcare products in the Nigeria and surrounding regions. When finished in southeast Nigeria in 2024, the manufacturing installation's initial phase will produce up to 5.5 million intravenous solution bags per year for use in Nigerian and other African hospitals and healthcare facilities.
  • In December 2020, Royal Philips, a health technology company, announced that it had signed an agreement to acquire Vesper Medical Inc., a U.S.-based medical technology company that develops minimally-invasive peripheral vascular devices. Vesper Medical will further expand Philips portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease. 

Intravenous Solutions Market Restraints

Growth of the global intravenous solution market is expected to be hampered over the forecast period, owing to increasing FDA recalls of IV products. For instance, in August 2018, the U.S. FDA recalled Becton Dickinson & Company’s NEXIVA Closed IV Catheter System Dual Port 18GA 1.25 IN (BD Nexiva catheter) due to failure in the needle tip shield/safety mechanism.

Key Players

Key players operating in the global intravenous solutions market include Baxter International Inc., ICU Medical. Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Solution
      • Market Snapshot, By Bag Type
      • Market Snapshot, By Application
      • Market Snapshot, By End User
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Epidemiology
    • Porter’s Five Forces Analysis
  4. Global Intravenous Solutions Market- Impact of Coronavirus (COVID-19) Pandemic
    • Overall Impact
    • COVID-19 Impact on the market
  5. Global Intravenous Solutions Market, By Solution, 2019 – 2031, (US$ Billion)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Saline
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Normal Saline (0.9% NaCl)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Hypertonic Saline
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Dextran
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Lactated Ringer’s
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Amino Acid
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Vitamins & Minerals
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Heparin and trace elements
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Mixed Solutions
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
  6. Global Intravenous Solutions Market, By Bag Type, 2019 – 2031, (US$ Billion)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020– 2031
      • Segment Trends
    • Large Volume Bags (greater than 250ml)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Small Volume Bags (less than 250ml)
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
  7. Global Intravenous Solutions Market, By Application, 2019 – 2031, (US$ Billion)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020– 2031
      • Segment Trends
    • Basic IV Solution
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Nutritional IV Solution
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Blood IV Solution
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Drug IV Solution
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Irrigation IV Solution
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
  8. Global Intravenous Solutions Market, By End User, 2019 – 2031, (US$ Billion)
    • Overview
      • Market Share Analysis, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, 2020 – 2031
      • Segment Trends
    • Hospital
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Clinics
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Ambulatory Surgery Centers
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
    • Home care Settings
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2019–2031, (US$ Billion)
  9. Global Intravenous Solutions Market, By Region, 2019 – 2031, (US$ Billion)
    • Introduction
      • Market Share Analysis, By Region, 2024 and 2031 (%)
      • Y-o-Y Growth Analysis, For Regions, 2020–2031
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 – 2031, (US$ Billion)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Solution, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Bag Type, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 – 2031, (US$ Billion)
        • North Africa
        • Central Africa
        • South Africa
  10. Competitive Landscape
    • Heat Map Analysis
    • Company Profile
      • Baxter International Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • ICU Medical, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • B. Braun Melsungen Ag
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Grifols, S.A
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Fresenius Kabi USA, LLC
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Vifor Pharma Management Ltd.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • JW Life Science
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Amanta Healthcare
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Axa Parenterals Ltd
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Salius Pharma Private Limited.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Pfizer, Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Otsuka Pharmaceutical Co., Ltd
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Ajinomoto Co., Inc.
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Braun Melsungen AG
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Soxa Formulations & Research Pvt. Ltd
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
      • Sichuan Kelun Pharmaceutical Co Ltd
        • Company Highlights
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Market Strategies
  11.  Analyst Recommendation
    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  12. Section
    • References
    • Research Methodology
    • About Us and Sales Contact

Detailed Segmentation:

  • Global Intravenous Solutions Market, By Solution type:
    • Saline
      • Normal Saline (0.9% NaCl)
      • Hypertonic Saline
    • Dextran
    • Lactated Ringer’s
    • Amino Acid
    • Vitamins & Minerals
    • Heparin and Trace Elements
    • Mixed Solutions
  • Global Intravenous Solutions Market, By Bag type:
    • Large Volume Bags (greater than 250ml)
    • Small Volume Bags (less than 250ml)
  • Global Intravenous Solutions Market, By Application:
    • Basic IV Solution
    • Nutritional IV Solution
    • Blood IV Solution
    • Drug IV Solution
    • Irrigation IV Solution
  • Global Intravenous Solutions Market, By End User:
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers
    • Home Care Settings
  • Global Intravenous Solutions Market, By Region:
    • North America
      • By Solution type:
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
      • By Country
        • U.S.
        • Canada
    • Latin America
      • By Solution type:
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
      • By Country 
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Solution type:
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
      • By Country 
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Solution type:
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
      • By Country
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Solution type:
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
      • By Country 
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Solution type:
        • Saline
          • Normal Saline (0.9% NaCl)
          • Hypertonic Saline
        • Dextran
        • Lactated Ringer’s
        • Amino Acid
        • Vitamins & Minerals
        • Heparin and Trace Elements
        • Mixed Solutions
      • By Bag type:
        • Large Volume Bags (greater than 250ml)
        • Small Volume Bags (less than 250ml)
      • By Application:
        • Basic IV Solution
        • Nutritional IV Solution
        • Blood IV Solution
        • Drug IV Solution
        • Irrigation IV Solution
      • By End User:
        • Hospitals
        • Clinics
        • Ambulatory Surgery Centers
        • Home Care Settings
        • Others
      • By Country
        • South Africa
        • Central Africa
        • North Africa
- Frequently Asked Questions -

What are the growth estimates for the global intravenous solutions market till 2031?

The global intravenous solutions market is estimated to surpass USD 16.69 Bn by 2031

Which are the prominent intravenous solutions market players across the globe?

Major players operating in the market include Baxter International Inc., ICU Medical. Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.

Which segment based on solution type, accounted for the highest demand in market of intravenous solutions in 2024?

Among solution type, Lactated Ringer’s segment generated significant revenue in 2024, owing to increasing approval by the key market players.

What are the key factors driving growth of the market?

Increasing launches and regulatory approvals for intravenous solution injection is expected to drive growth of the market.

What is the Compound Annual Growth Rate (CAGR) of the market till 2031?

The market is estimated to exhibit a CAGR of 6.1% over the forecast period.

Which region is dominating the market growth?

Among regions, North America is expected to witness significant growth over the forecast period, owing to increasing launches of parenteral (intravenous) nutrition (PN) products.
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.
Buy Now with Special Discount
Customize Now